Scarica l'app Stockscreener
0.6303
1.73%
-0.0111
Dopo l'orario di chiusura:
.64
0.0097
+1.54%
Precedente Chiudi:
$0.6414
Aprire:
$0.6272
Volume 24 ore:
150.40K
Relative Volume:
0.17
Capitalizzazione di mercato:
$30.59M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-0.6061
EPS:
-1.04
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
-0.51%
1M Prestazione:
-36.97%
6M Prestazione:
-40.54%
1 anno Prestazione:
-56.23%
Intervallo 1D:
$0.6236
$0.651
Intervallo di 1 settimana:
$0.615
$0.67
Portata 52W:
$0.5588
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Nome
Werewolf Therapeutics Inc
Settore
Industria
Telefono
617-952-0555
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Confronta HOWL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.6303 | 31.13M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-04-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-08-24 | Iniziato | Wedbush | Outperform |
| 2023-06-06 | Ripresa | Jefferies | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-25 | Iniziato | Evercore ISI | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-25 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Can Werewolf Therapeutics Inc. stock hit analyst price targetsPortfolio Value Summary & Verified Technical Trade Signals - ulpravda.ru
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 By Investing.com - Investing.com India
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 - Investing.com
Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Werewolf Therapeutics (HOWL) - The Globe and Mail
Market Moves: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Summary & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Werewolf Therapeutics Inc. stock benefit from infrastructure spendingProduct Launch & Free Accurate Trade Setup Notifications - Улправда
Is Werewolf Therapeutics Inc. stock ready for breakoutJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
Werewolf Therapeutics (NASDAQ:HOWL) Downgraded to “Neutral” Rating by Wedbush - Defense World
Why retail investors pile into Werewolf Therapeutics Inc. stockRisk Management & Technical Confirmation Trade Alerts - Улправда
HC Wainwright & Co. Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update By Investing.com - Investing.com Nigeria
Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3 - marketscreener.com
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update - Investing.com Nigeria
Werewolf Therapeutics advances Inducer platform candidates - BioWorld MedTech
Werewolf Therapeutics Announces Pipeline and Business Updates - Investing News Network
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities - TipRanks
Werewolf Therapeutics Incplans for two INDs by mid-2027 - marketscreener.com
Werewolf Therapeutics, Inc. Announces Pipeline Update and 2026 Priorities - TradingView — Track All Markets
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 14,548 Shares of Stock - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 9,983 Shares of Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 23,640 Shares - MarketBeat
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why - MSN
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - sharewise.com
What analysts say about Werewolf Therapeutics Inc stockInsider Trading Activity & Free Superior Stock Performance - earlytimes.in
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 17,858 Shares - MarketBeat
Luke Evnin Sells 37,104 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells $29,969.63 in Stock - MarketBeat
Werewolf Therapeutics, Inc. (HOWL) director discloses Rule 10b5-1 stock sales - Stock Titan
IPO Launch: What is the fair value of Werewolf Therapeutics Inc stock nowWeekly Investment Report & Momentum Based Trading Signals - moha.gov.vn
How Werewolf Therapeutics Inc. stock benefits from global expansionEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
What is the fair value of Werewolf Therapeutics Inc. stock nowStop Loss & Daily Profit Maximizing Tips - Newser
Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock - Investing.com India
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k - Investing.com India
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k - Investing.com
A new trading data show Werewolf Therapeutics Inc (HOWL) is showing positive returns. - Setenews
Owner MPM BioVentures 2014 LP Files To Sell 130,125 Of Werewolf Therapeutics Inc [HOWL] - TradingView — Track All Markets
Will Werewolf Therapeutics Inc. stock benefit from green energy trends - Newser
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k By Investing.com - Investing.com India
Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):